We could not find your search for PSSI Please try again.
Please check our suggestions as you type in the search box.
Bearish
Nov 08, 2012 | 8:21 AM EST
PSSI was downgraded to Neutral from Buy, UBS said. $29 price target. 10Q reveals inline results. 
Bullish
May 21, 2012 | 8:23 AM EDT
PSSI was initiated with a Buy rating, UBS said.  $26 price target.  Market has overcorrected the stock price. 
Bearish
May 11, 2012 | 6:43 AM EDT
PSSI was downgraded from Outperform to Neutral, Robert Baird said. $21 price target. Company missed expectations again and lacks near-t...
Medical equipment makers and suppliers could be just the right remedy.

Columnist Conversations

Kulicke & Soffa(+7%)is in full breakout mode today. The stock opened with an upside gap that pushed ...
Seemed as if comments related to inflation were a table setter in pushing out the first rate increase until th...
While many are concerned about a negative reaction if the Fed doesn't hint at pushing out interest rate hikes ...
We are nearly to the Fed decision and this time around expectations for what's to come are rather muted. No m...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.